Alexandra G Ellis
Overview
Explore the profile of Alexandra G Ellis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Drucker A, Lam M, Prieto-Merino D, Malek R, Ellis A, Yiu Z, et al.
JAMA Dermatol
. 2024 Jul;
160(9):936-944.
PMID: 39018058
Importance: There are multiple approved systemic treatments for atopic dermatitis. Lebrikizumab is a newly licensed biologic medication that has been compared to placebo in clinical trials but not to other...
2.
Drucker A, Lam M, Elsawi R, Prieto-Merino D, Malek R, Ellis A, et al.
Br J Dermatol
. 2023 Oct;
190(2):184-190.
PMID: 37831594
Background: Systemic treatments for atopic dermatitis (AD) are evaluated primarily in placebo-controlled trials with binary efficacy outcomes. In a living systematic review and network meta-analysis (NMA), we previously analysed continuous...
3.
Gerds A, Castro C, Snopek F, Flynn M, Ellis A, Manning M, et al.
J Comp Eff Res
. 2023 Aug;
12(9):e230066.
PMID: 37531245
Patients with polycythemia vera (PV), a rare and chronic blood cancer, are at a higher risk for thromboembolic events, progression to myelofibrosis, and leukemic transformation. In 2021, ropeginterferon alfa-2b-njft (BESREMi)...
4.
Drucker A, Morra D, Prieto-Merino D, Ellis A, Yiu Z, Rochwerg B, et al.
JAMA Dermatol
. 2022 Mar;
158(5):523-532.
PMID: 35293977
Importance: Systemic treatments for atopic dermatitis are being evaluated primarily in placebo-controlled trials; network meta-analysis can provide relative efficacy and safety estimates for treatments that have not been compared head...
5.
Burton B, Ellis A, Orr B, Chatlani S, Yoon K, Shoaff J, et al.
Mol Genet Metab
. 2021 Jul;
134(1-2):182-187.
PMID: 34304992
Background: Niemann-Pick Disease Type C (NPC) is an ultra-rare progressive neurodegenerative disease caused by autosomal recessive mutations in the NPC1 or NPC2 genes that lead to premature death, with most...
6.
Thokala P, Stevenson M, Kumar V, Ren S, Ellis A, Chapman R
Cost Eff Resour Alloc
. 2020 Oct;
18:41.
PMID: 33041673
Background: Patients with infantile-onset spinal muscular atrophy (SMA), a rare, genetic neuromuscular disease, do not achieve key motor function milestones (e.g., sitting) and have short life expectancy in the absence...
7.
Ellis A, Iskandar R, Schmid C, Wong J, Trikalinos T
Stat Med
. 2020 Aug;
39(25):3521-3548.
PMID: 32779814
An emulator is a fast-to-evaluate statistical approximation of a detailed mathematical model (simulator). When used in lieu of simulators, emulators can expedite tasks that require many repeated evaluations, such as...
8.
Drucker A, Ellis A, Bohdanowicz M, Mashayekhi S, Yiu Z, Rochwerg B, et al.
JAMA Dermatol
. 2020 Apr;
156(6):659-667.
PMID: 32320001
Importance: Most clinical trials assessing systemic immunomodulatory treatments for patients with atopic dermatitis are placebo-controlled. Objective: To compare the effectiveness and safety of systemic immunomodulatory treatments for patients with atopic...
9.
Fehnel C, Gormley W, Dasenbrock H, Lee Y, Robertson F, Ellis A, et al.
J Am Heart Assoc
. 2017 Oct;
6(10).
PMID: 29066443
Background: Older patients with aneurysmal subarachnoid hemorrhage (aSAH) are unique, and determinants of post-acute care outcomes are not well elucidated. The primary objective was to identify hospital characteristics associated with...
10.
Ellis A, Trikalinos T, Wessler B, Wong J, Dahabreh I
Am J Epidemiol
. 2017 Oct;
187(5):1064-1078.
PMID: 28992207
This review examines the conduct and reporting of observational studies using propensity score-based methods to compare coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), or medical therapy for patients...